Diffuse Large B-cell Lymphoma

DLBCL is a rare, B-cell non-Hodgkin’s lymphoma that affects older adults.

Dose-Adjusted EPOCH for B-Cell Lymphomas May Be Safe, Cost Effective in the Outpatient Setting

Researchers found that dose-adjusted (DA-) etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (EPOCH) for B-cell lymphomas can be administered safely in the outpatient setting and that outpatient administration was associated with significant savings relative to inpatient administration. Wenhui Li, PharmD, of the H. Lee Moffitt Cancer Center in Tampa, Florida, and colleagues published their findings in…

Next post in Lymphoma